Search research articles
Contact Us
Filters
Showing results (21-30 of 161) with videos related to
Page
of 17
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 10, 2018
Patient empowerment in Europe: is no further research needed?
Livio Garattini, Anna Padula
Vaccine
|
January 29, 2011
Re: The health technology assessment of bivalent HPV vaccine Cervarix® in Italy
Livio Garattini, Anna Padula
International Journal of Technology Assessment in Health Care
|
March 25, 2011
Risk sharing agreements: what lessons from Italy?
Livio Garattini, Gianluigi Casadei
European Journal of Internal Medicine
|
January 21, 2025
Obesity in Europe: Less impact on chronic diseases thanks to internists?
Livio Garattini, Antonino Mazzone
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 11, 2017
Competition in pharmaceuticals: more product- than price-oriented?
Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine
|
January 25, 2017
Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?
Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 12, 2006
Pharmaceutical policy in Italy: Theory, politics and practice
Livio Garattini, Dante Cornago
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 22, 2018
Pharmaceutical pricing conundrum: time to get rid of it?
Livio Garattini, Anna Padula
Expert Opinion on Therapeutic Patents
|
July 4, 2017
Between pharmaceutical patents and European patients: is a compromise still possible?
Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 3, 2020
Correction to: Defensive medicine in Europe: a 'full circle'?
Livio Garattini, Anna Padula
Page
of 17
Search research articles
Search
Showing results (21-30 of 161) with videos related to
Sort By:
Page
of 17
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 10, 2018
Patient empowerment in Europe: is no further research needed?
Livio Garattini, Anna Padula
Vaccine
|
January 29, 2011
Re: The health technology assessment of bivalent HPV vaccine Cervarix® in Italy
Livio Garattini, Anna Padula
International Journal of Technology Assessment in Health Care
|
March 25, 2011
Risk sharing agreements: what lessons from Italy?
Livio Garattini, Gianluigi Casadei
European Journal of Internal Medicine
|
January 21, 2025
Obesity in Europe: Less impact on chronic diseases thanks to internists?
Livio Garattini, Antonino Mazzone
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 11, 2017
Competition in pharmaceuticals: more product- than price-oriented?
Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine
|
January 25, 2017
Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?
Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 12, 2006
Pharmaceutical policy in Italy: Theory, politics and practice
Livio Garattini, Dante Cornago
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 22, 2018
Pharmaceutical pricing conundrum: time to get rid of it?
Livio Garattini, Anna Padula
Expert Opinion on Therapeutic Patents
|
July 4, 2017
Between pharmaceutical patents and European patients: is a compromise still possible?
Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 3, 2020
Correction to: Defensive medicine in Europe: a 'full circle'?
Livio Garattini, Anna Padula
Page
of 17